Evolution of Public Health Human Papillomavirus Immunization Programs in Canada
| Autor: | Eduardo L. Franco, Smita Kothari, G. Yen, Voica Racovitan, Parambir Bhangu, Alexandra Goyette |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty Canada Vaccination schedule 030231 tropical medicine Alphapapillomavirus Article 03 medical and health sciences 0302 clinical medicine Humans Medicine Papillomavirus Vaccines 030212 general & internal medicine Human papillomavirus human papillomavirus RC254-282 Ontario Immunization Programs business.industry Public health Neoplasms. Tumors. Oncology. Including cancer and carcinogens Hpv vaccination vaccination public health programs vaccine policy Vaccination Immunization Vaccination coverage school health services Female Public Health business Demography |
| Zdroj: | Current Oncology Volume 28 Issue 1 Pages 97-1007 Current Oncology, Vol 28, Iss 97, Pp 991-1007 (2021) |
| ISSN: | 1718-7729 |
| DOI: | 10.3390/curroncol28010097 |
| Popis: | Background: Since 2007, all Canadian provinces and territories have had a publicly funded program for vaccination against human papillomavirus (HPV) infection. The objective of this study was to describe the evolution of these vaccination programs. Methods: This was a targeted literature review of public HPV vaccination programs and vaccination coverage rates, based on information provided by jurisdictional public health authorities. Results: HPV vaccination of schoolgirls began in school years 2007/08 to 2010/11 with three doses of the quadrivalent HPV vaccine in all provinces except Quebec, which started with two doses. By 2018/19, all jurisdictions were vaccinating with two doses of the nonavalent vaccine in both girls and boys, except Quebec, which used a mixed vaccination schedule with one dose of the nonavalent and one dose of the bivalent vaccines. Public HPV vaccination programs in most provinces include after-school catch-up vaccination. Immunocompromised or other high-risk individuals are eligible for the HPV public vaccination program in most provinces, but policies vary by jurisdiction. In 2017/18, vaccination coverage rates in provincial HPV school-based programs varied from 62% in Ontario to 86% in Prince Edward Island in girls and from 58% in Ontario to 86% in Prince Edward Island in boys. Conclusions: Since their introduction, Canadian school-based HPV public vaccination programs have evolved from a three-dose to a two-dose schedule, from a quadrivalent to a nonavalent vaccine, and from a girls-only to a gender-neutral policy. Vaccination coverage rates have varied markedly and only Prince Edward Island and Newfoundland/Labrador have maintained rates exceeding 80%. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|